(Q41817909)

12 October 2017

Chemotherapy-induced regression of an adrenocorticotropin-secreting pituitary carcinoma accompanied by secondary adrenal insufficiency (English)

1 reference

12 October 2017

1 reference

Robert Frank Cornell

1

1 reference

12 October 2017

Daniel F Kelly

2

1 reference

12 October 2017

Gal Bordo

3

1 reference

12 October 2017

Ty B Carroll

4

1 reference

12 October 2017

Huy T Duong

5

1 reference

12 October 2017

Julie Kim

6

1 reference

12 October 2017

Yuki Takasumi

7

1 reference

12 October 2017

James P Thomas

8

1 reference

12 October 2017

Yee Lan Wong

9

1 reference

12 October 2017

James W Findling

10

1 reference

12 October 2017

22 December 2013

1 reference

Case reports in endocrinology

12 October 2017

1 reference

12 October 2017

2013

1 reference

12 October 2017

675298

1 reference

Creative Commons Attribution 3.0 Unported

12 October 2017

start time

1 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3881387

New targeted therapies in pituitary carcinoma resistant to temozolomide

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3881387

A case of corticotroph carcinoma that caused multiple cranial nerve palsies, destructive petrosal bone invasion, and liver metastasis.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3881387

Temozolomide for corticotroph pituitary adenomas refractory to standard therapy.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3881387

Temozolomide treatment for aggressive pituitary tumors: correlation of clinical outcome with O(6)-methylguanine methyltransferase (MGMT) promoter methylation and expression

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3881387

Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3881387

Malignant pituitary corticotroph adenomas: report of two cases and a comprehensive review of the literature.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3881387

Clinical review: Diagnosis and management of pituitary carcinomas.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3881387

Corticotroph carcinoma of the pituitary: a clinicopathological study. Report of four cases

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3881387

p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3881387

A Pituitary Parasellar Tumor with Extracranial Metastases and High, Partially Suppressible Levels of Adrenocorticotropin and Related Peptides*

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3881387

Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3881387

Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3881387

Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3881387

High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3881387

Use of temozolomide in aggressive pituitary tumors: case report

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3881387

Treatment of Nelson's syndrome with temozolomide

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3881387

Corticotroph carcinoma presenting as a silent corticotroph adenoma

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3881387

A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease

18 August 2018

1 reference

12 December 2020

Aggressive silent corticotroph adenoma progressing to pituitary carcinoma: the role of temozolomide therapy

1 reference

12 December 2020

Corticotropin-releasing hormone- and adrenocorticotropin-producing pituitary carcinoma with metastases to the liver and lung in a patient with Cushing's disease

1 reference

12 December 2020

A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumours: secreting versus non-secreting adenomas

1 reference

12 December 2020

Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy

1 reference

12 December 2020

Expression of p53 protein in pituitary adenomas

1 reference

12 December 2020

Identifiers

DOI

10.1155/2013/675298

1 reference

12 October 2017

1 reference

12 October 2017

PubMed publication ID

24455332

1 reference